Home Life Sciences Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
Article Open Access

Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report

  • Qi Wang , Xuehai Xie , Yinmo Yang and Xiaodong Tian EMAIL logo
Published/Copyright: November 29, 2025

Abstract

Primary hepatic angiosarcoma (PHA) is a rare malignancy, and the occurrence of a dual malignancy involving both gastric cancer (GC) and PHA is even more exceptional. Here, we present a case of a 63-year-old man who complained of hiccups. PET-CT and Abdomen & Pelvis Routine Enhanced Scan results revealed a single liver mass and thickening of the inner wall of the gastric antrum. The pathologic biopsy confirmed the presence of GC in the antrum along the greater curvature. The initial diagnosis indicated GC with solitary liver metastasis, given the rarity of PHA. The patient underwent a radical distal gastrectomy and right posterior hepatic lobectomy. Postoperative pathology revealed early GC and PHA without any signs of lymphatic or distant metastases.

1 Introduction

Gastric cancer (GC) is a prevalent malignant tumor that originates from epithelial cells in the stomach, ranking third in both incidence and mortality rates in China [1]. For early gastric cancer (EGC) patients who undergo endoscopic submucosal dissection (ESD), the 5-year rates of overall survival (OS), disease-specific survival, and relative survival were 92.6, 99.9, and 105.0%, respectively [2]. However, EGC with lymph node metastases has a relatively poor prognosis even after standard surgery [3]. Comprehensive therapies, including adjuvant and palliative chemotherapy, could be considered for these patients as well as those with advanced stages. Despite advancements in understanding the biological aspects of GC, surgical dissection or ESD remains a crucial cornerstone in the treatment with curative intent [4,5].

Primary hepatic angiosarcoma (PHA) is a rare and highly aggressive neoplasm that originates from the endothelial cells of blood vessels or lymphatic vessels. Approximately 200 cases are diagnosed annually worldwide [6]. Epidemiological prospective research indicates an incidence rate of PHA at approximately 0.5–2.5 cases per 10 million individuals [7]. Despite its rarity, it is the most common primary malignant mesenchymal tumor of the liver [6]. PHA is associated with prolonged latency following exposure to known chemical carcinogens such as vinyl chloride; however, 75% of the patients with no identifiable etiology [6,8]. Typically, PHA manifests in older men, with the highest incidence occurring in the sixth decade of life, and males are more commonly affected than females, with a ratio of 3–4:1 [6]. PHA is a rapid fatal neoplasm, with most patients succumbing within 6 months due to hepatic insufficiency or hemorrhagic complications [9,10]. Only 3% of the patients live more than 2 years with treatment [11], and the life expectancy after a liver transplant is less than 7 months [12]. Therefore, early diagnosis and radical resection of the tumor are crucial for effective treatment.

Multiple primary cancer (MPC) refers to the presence of more than one distinct malignant tumor diagnosed in a single patient, either concurrently or consecutively [13]. According to the criteria proposed by the World Health Organization in 2005 [14]: 1. the malignancy of each tumor must be confirmed through pathological examination; 2. each tumor must exhibit unique pathological morphology; 3. the tumors must occur at different sites; and 4. tumor metastasis must be excluded. Here, we present a case in which the patient was diagnosed with concurrent GC and HPA. Our aim is to provide evidence supporting surgical intervention as the optimal approach for early PHA. Additionally, we emphasize the importance of prioritizing liver puncture to identify the nature of digestive system tumors with a single hepatic mass. Such patients should also be given priority for surgical treatment rather than preoperative neoadjuvant therapy.

2 Case report

A 63-year-old male patient, who had a habit of consuming pickled foods, was admitted to the hospital due to persistent hiccups lasting for over 6 months. A gastroscopic examination conducted at a local hospital revealed an off-white lesion measuring 2.0 cm × 2.0 cm in the antrum of the stomach (Figure 1a). Pathologic examination revealed the presence of high-grade dysplasia and intramucosal adenocarcinoma. Subsequently, the patient was referred to Peking University First Hospital for surgery.

Figure 1 
               (a) The endoscopic biopsies confirmed the presence of gastric antrum cancer accompanied by mild chronic atrophic gastritis (C-2type) in the lesion located around the great curvature side of the antrum; (b) the Abdomen & Pelvis Routine Enhanced Scan CT detected the presence of a gastric lesion in the patient; (c) the postoperative specimen of GC; (d) the histopathological findings, encompassing hematoxylin and eosin (HE) staining and CK immunohistochemistry, unequivocally confirmed the presence of GC in the gastric lesion.
Figure 1

(a) The endoscopic biopsies confirmed the presence of gastric antrum cancer accompanied by mild chronic atrophic gastritis (C-2type) in the lesion located around the great curvature side of the antrum; (b) the Abdomen & Pelvis Routine Enhanced Scan CT detected the presence of a gastric lesion in the patient; (c) the postoperative specimen of GC; (d) the histopathological findings, encompassing hematoxylin and eosin (HE) staining and CK immunohistochemistry, unequivocally confirmed the presence of GC in the gastric lesion.

The physical assessment showed no notable abnormalities, and tumor markers, including alpha-fetoprotein (AFP), carcinoembryonic antigen, carbohydrate antigen 19-9, total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA), fPSA/tPSA (f/t), squamous cell carcinoma associated antigen, cytokeratin 19 fragments (CYFRA21-1), neuron-specific enolase, carbohydrate antigen 72-4, pro-gastrin-releasing peptide, and carbohydrate antigen 24-2, were within normal range. The Abdomen & Pelvis Routine Enhanced CT scan revealed thickening of the inner wall of the gastric antrum (Figure 1b). Additionally, the enhanced CT scan showed a solitary mass in the liver with ring-like enhancement at the periphery in the arterial phase, indistinct boundaries during the venous phase, and ring-like enhancement at the edges in the subsequent delayed phase (Figure 2a). The solitary hepatic mass was initially identified as a metastatic lesion originating from GC, consistent with the liver being the primary site of metastasis for tumors originating from the digestive system. PET-CT, used for detecting metastases, showed elevated glucose metabolism in the hepatic lesion (Figure 2b).

Figure 2 
               (a) The Abdomen & Pelvis Routine Enhanced Scan CT revealed a solitary hepatic lesion; (b) the PET-CT scan confirmed elevated glucose metabolism in the hepatic lesion; (c) the liver specimen; (d) the histopathological findings encompassing HE staining, CD31 immunohistochemistry, ERG immunostaining, and CK immunohistochemistry, unequivocally confirmed the presence of hepatic angiosarcoma in the liver specimen.
Figure 2

(a) The Abdomen & Pelvis Routine Enhanced Scan CT revealed a solitary hepatic lesion; (b) the PET-CT scan confirmed elevated glucose metabolism in the hepatic lesion; (c) the liver specimen; (d) the histopathological findings encompassing HE staining, CD31 immunohistochemistry, ERG immunostaining, and CK immunohistochemistry, unequivocally confirmed the presence of hepatic angiosarcoma in the liver specimen.

A successful radical distal gastrectomy and resection of the right posterior lobe of the liver were performed, as surgery is the optimal therapeutic approach for this patient [15]. Following the operation, the hiccup symptom was significantly relieved. The gastric lesion, measuring 22 mm × 20 mm × 5 mm and accompanied by a superficial ulcer (Figure 1c), was diagnosed as early-stage gastric cancer (T1bN0M0) (Figure 1d). Immunohistochemical analysis of the 33 mm × 25 mm × 25 mm mass in the right liver (Figure 2c) demonstrated positive expression of CD31 [6], ERG [16], and negative expression of CK markers (Figure 2d), leading to a diagnosis of PHA. Fortunately, the patient’s GC and PHA showed no evidence of lymph node metastases or distant metastases. The patient recovered well and was discharged from the hospital. He was advised to undergo a review of tumor markers, and abdominal CT scans every 3 months. At 36-month follow-up, he remained well and disease-free with no subsequent need for chemotherapy.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has complied with all the relevant national regulations and institutional policies, is in accordance with the tenets of the Helsinki Declaration, and has been approved by the Peking University First Hospital (2024 study 194-002).

3 Discussion

This special case presents two distinctive characteristics. First, PHA, an aggressive and rare tumor, poses a challenge due to the lack of established and effective treatment guidelines owing to its low frequency [6]. Second, the concurrent EGC adds to the rarity of this case.

In this case, the patient initially presented with gastrointestinal symptoms and a solitary mass in the liver was detected during a CT scan. Given the rarity of PHA, the negative of AFP, and the liver being identified as the primary site of metastasis for GC [17], our initial diagnosis for the patient was primary GC with solitary hepatic metastasis. In light of this, the patient was presented with two options: neoadjuvant chemotherapy followed by surgical intervention or direct progression to surgery. In recent decades, there has been an evaluation of comprehensive therapy methods involving a combination of surgery, chemotherapy, and gastrectomy with trans-arterial chemoembolization plus systemic chemotherapy (GTC) in patients with GC and liver metastasis [18]. Some patients are ineligible for surgical procedures due to the association of liver metastasis with extrahepatic diseases, such as peritoneal dissemination, lymph node metastasis, and direct invasion of other organs by cancer [19]. However, Saiura et al. [20] argued that patients with liver metastasis from GC who undergo hepatic resection have a higher likelihood of long-term survival in the absence of lymph node metastasis at the primary site. Markar et al. [15] found that among patients diagnosed with GC, those who underwent curative surgery combined with hepatectomy had a better survival time compared to those who only underwent gastrectomy, and their survival time was similar to that of patients undergoing gastrectomy without liver metastasis. Other studies have also suggested that surgical resection of liver metastases from GC may benefit patients with solitary metastasis [21,22,23]. The successful surgical procedure involved distal gastrectomy and resection of the right posterior lobe of the liver. This decision was prompted by the presence of a solitary liver mass and the absence of metastases on PET-CT. Subsequent pathological analysis confirmed that the liver lesion is PHA based on the immunohistochemistry evidence and immune markers.

PHA typically presents as a multicentric occurrence involving both lobes of the liver, with multifocal masses occasionally affecting the entire hepatic tissue [6]. Abdominal pain was the most common symptom for 66% of the patients, while 12.5% of the patients presented with atypical symptoms [16]. Patients may also present with ascites, heart palpitations, cough, hepatomegaly, acute abdominal crisis, backache, weakness, weight loss, fever, anemia, hemoperitoneum, and other symptoms indicative of distant metastases (such as lung, peritoneum, bone, and spleen) [6,9,11,16]. In this study, the primary symptom in this patient was persistent hiccups, not hepatic discomfort, despite the presence of a large mass in the liver. Due to the absence of specific imaging features, pathological biopsy remains the primary diagnostic method. However, fine needle aspiration cytology is limited by the potential risk of fatal hemorrhage [24]. CD31 [6] and ERG [16] have been proven to be sensitive and specific diagnostic markers. Vimentin, GPC-3, desmin, Ki-67, CD34, and factor VIII-related antigens have been reported as positive in PHA [6,16]. The pathological findings in this case were consistent with the aforementioned markers. It is worth noting that while the cytokeratin expression of PHA in this case is negative, some angiosarcomas have been shown to be positive for cytokeratin [25,26]. In the absence of CD31 and ERG expression, a positive cytokeratin result may lead to the misdiagnosis of the tumor as epithelial in origin.

Radical surgical resection appears to be the most effective treatment method for PHA [10]. Due to the lack of noticeable symptoms and the aggressive nature of PHA, only 20% of the cases are considered suitable for hepatic resection [6]. Liver transplantation appears to be an effective treatment option for patients with entire liver involvement by tumors. However, certain studies have cautioned against performing liver transplantation in patients with PHA due to the high recurrence rate and rapid disease progression, which leads to a median survival of less than 7 months post-transplantation [12,27]. Kim et al. [28] demonstrated that chemotherapy improved survival rates in 2 out of 4 patients with advanced PHA and distant metastasis. The study recommended the utilization of 5-FU-carboplatin in combination with doxorubicin or ifosfamide for treatment. Palliative chemotherapy may be the only treatment option available for those patients. A study showed that the median OS and disease-free survival of patients with PHA after surgical resection were 18 months (range: 3–144 months) and 10 months (range: 2–144 months), respectively [29]. In a study involving six patients diagnosed with PHA and presenting with a solitary mass, three patients underwent right hepatectomy, one patient underwent extended right hepatectomy, and two patients underwent left hepatectomy. Among these patients, two survived for more than 12 months post-surgery, and one patient achieved a survival period of over 29 months without recurrence [30]. In this case, although the PHA volume measured 33 mm × 25 mm × 25 mm, postoperative pathology revealed no signs of lymph node metastasis, and PET-CT indicated no distant metastasis. The patient did not receive chemotherapy following surgery but was advised to undergo a review every 3 months. Presently, it has been 36 months since the surgery, and no recurrence has been observed. This case helps bolster our support for surgery as the optimal treatment for PHA, capable of extending patients’ survival.

In this case, whether it was GC or PHA, the patient did not exhibit typical symptoms. GC is currently believed to be primarily caused by H. pylori infection, autoimmune atrophic gastritis, and poor dietary habits, while PHA is primarily associated with exposure to known chemical carcinogens over a prolonged period, although 75% of the patients have no known etiology [6]. The etiologies of the two conditions do not significantly overlap. Furthermore, there have been no previous reports, to the best of our knowledge, of both occurring simultaneously or sequentially in a single patient. Genetic testing was conducted for the patient’s two tumors. In the case of GC, we detected 0 primary mutations, 1 secondary mutation (VEGFA), and 7 tertiary mutations (ASXL1, CARD11, CDKN2A, E2F3, GRIN2A, PIK3CA, and TP53). Interestingly, the above-mentioned mutated genes were not detected in the PHA. This indicates that the patient’s GC and PHA are not directly related. Additionally, both PHA and GC are MSS/MSI-L.

In summary, it is important to carefully consider the potential presence of PHA in AFP-free cases where an endoscopic biopsy indicates EGC and a CT scan reveals a hepatic mass. While standardized treatment guidelines for PHA are still being developed, surgical intervention remains the optimal choice for patients with a solitary hepatic mass. In the absence of a lymph node or distant metastatic PHA, chemotherapy may not be necessary. Additionally, we recommend prioritizing surgical treatment for patients with GC accompanied by a solitary liver mass, regardless of whether the liver mass is a metastasis.


tel: +86-13911636280

Acknowledgments

The authors are grateful for the reviewer’s valuable comments that improve the manuscript.

  1. Funding information: This study was supported in part by grants 81572339 (to X. Tian), 81672353, and 81871954 (to Y. Yang) from the National Natural Science Foundation of China.

  2. Author contributions: Qi Wang wrote the main manuscript text, Xuehai Xie was involved in the data analysis, Yinmo Yang reviewed the manuscript, and Xiaodong Tian provided fund support and oversaw the project.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90.10.1097/CM9.0000000000002108Search in Google Scholar PubMed PubMed Central

[2] Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205.10.1007/s10120-015-0469-0Search in Google Scholar PubMed

[3] Wang Z, Ma L, Zhang XM, Zhou ZX. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China. Asian Pac J Cancer Prev. 2014;15(17):7219–22.10.7314/APJCP.2014.15.17.7219Search in Google Scholar

[4] Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48.10.1016/S0140-6736(20)31288-5Search in Google Scholar PubMed

[5] Röcken C. Molecular classification of gastric cancer. Expert Rev Mol Diagn. 2017;17(3):293–301.10.1080/14737159.2017.1286985Search in Google Scholar PubMed

[6] Chaudhary P, Bhadana U, Singh RA, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015;41(9):1137–43.10.1016/j.ejso.2015.04.022Search in Google Scholar PubMed

[7] Zocchetti C. Liver angiosarcoma in humans: epidemiologic considerations. Med Lav. 2001;92(1):39–53.Search in Google Scholar

[8] Elliott P, Kleinschmidt I. Angiosarcoma of the liver in Great Britain in proximity to vinyl chloride sites. Occup Environ. Med. 1997;54(1):14–8.10.1136/oem.54.1.14Search in Google Scholar PubMed PubMed Central

[9] Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci. 2003;48(4):677–82.10.1023/A:1022868221670Search in Google Scholar

[10] Zheng YW, Zhang XW, Zhang JL, Hui ZZ, Du WJ, Li RM, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol. 2014;29(5):906–11.10.1111/jgh.12506Search in Google Scholar PubMed

[11] Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltim). 1979;58(1):48–64.10.1097/00005792-197901000-00003Search in Google Scholar PubMed

[12] Chi TY, Yang ZY, Xue HD, Lü K, Feng RE, Xu HF, et al. Diagnosis and treatment of primary hepatic angiosarcoma: a report of 7 cases with a literature review. Zhonghua Yi Xue Za Zhi. 2011;91(24):1694–7.Search in Google Scholar

[13] Nagura E, Kawashima K, Yamada K. Multiple primary cancers associated with hematological malignancies. Jpn J Clin Oncol. 1985;15(Suppl 1):211–22.Search in Google Scholar

[14] Report WG. International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev. 2005;14(4):307–8.10.1097/00008469-200508000-00002Search in Google Scholar PubMed

[15] Markar SR, Mackenzie H, Mikhail S, Mughal M, Preston SR, Maynard ND, et al. Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England. Gastric Cancer. 2017;20(2):379–86.10.1007/s10120-016-0604-6Search in Google Scholar PubMed

[16] Wang ZB, Yuan J, Chen W, Wei LX. Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma. World J Gastroenterol. 2014;20(13):3672–9.10.3748/wjg.v20.i13.3672Search in Google Scholar PubMed PubMed Central

[17] Riihimäki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7(32):52307–16.10.18632/oncotarget.10740Search in Google Scholar PubMed PubMed Central

[18] Liu SF, Lu CR, Cheng HD, Xi HQ, Cui JX, Li JY, et al. Comparison of therapeutic efficacy between gastrectomy with transarterial chemoembolization plus systemic chemotherapy and systemic chemotherapy alone in gastric cancer with synchronous liver metastasis. Chin Med J (Engl). 2015;128(16):2194–201.10.4103/0366-6999.162497Search in Google Scholar PubMed PubMed Central

[19] Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol. 2003;27(10):1302–12.10.1097/00000478-200310000-00002Search in Google Scholar PubMed

[20] Saiura A, Umekita N, Inoue S, Maeshiro T, Miyamoto S, Matsui Y, et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology. 2002;49(46):1062–5.Search in Google Scholar

[21] Lim JK, Ahn JB, Cheon SH, Chang H, Jung JY, Rha SY, et al. Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports. Cancer Res Treat. 2006;38(3):184–8.10.4143/crt.2006.38.3.184Search in Google Scholar PubMed PubMed Central

[22] Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133(5):507–11.10.1067/msy.2003.147Search in Google Scholar PubMed

[23] Nonaka Y, Hiramatsu K, Kato T, Shibata Y, Yoshihara M, Aoba T, et al. Evaluation of hepatic resection in liver metastasis of gastric cancer. Indian J Surg Oncol. 2019;10(1):204–9.10.1007/s13193-018-0827-6Search in Google Scholar PubMed PubMed Central

[24] Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Rev Radiol. 1991;178(1):253–8.10.1148/radiology.178.1.1984314Search in Google Scholar PubMed

[25] Agaimy A, Kirsche H, Semrau S, Iro H, Hartmann A. Cytokeratin-positive epithelioid angiosarcoma presenting in the tonsil: a diagnostic challenge. Hum Pathol. 2012;43(7):1142–7.10.1016/j.humpath.2011.10.018Search in Google Scholar PubMed

[26] Salehi M, Rehman S, Davis S, Jafari HR. Angiosarcoma of gallbladder, a literature review. J Med Case Rep. 2024;18(1):62.10.1186/s13256-023-04323-zSearch in Google Scholar PubMed PubMed Central

[27] Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, et al. Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation–the European Liver Transplant Registry experience. Transplantation. 2013;95(6):872–7.10.1097/TP.0b013e318281b902Search in Google Scholar PubMed

[28] Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol. 2009;20(4):780–7.10.1093/annonc/mdn702Search in Google Scholar PubMed

[29] Tripke V, Heinrich S, Huber T, Mittler J, Hoppe-Lotichius M, Straub BK, et al. Surgical therapy of primary hepatic angiosarcoma. BMC Surg. 2019;19(1):5.10.1186/s12893-018-0465-5Search in Google Scholar PubMed PubMed Central

[30] Zhou YM, Li B, Yin ZM, Xu F, Wang B, Xu W, et al. Results of hepatic resection for primary hepatic angiosarcoma in adults. Med Sci Monit. 2010;16(2):CR61-6.Search in Google Scholar

Received: 2024-03-24
Revised: 2024-07-27
Accepted: 2024-08-09
Published Online: 2025-11-29

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  3. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  4. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  5. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  6. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  7. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  8. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  9. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  10. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  11. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  12. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  13. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  14. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  15. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  16. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  17. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  18. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  19. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  20. Changes in blood glucose and metabolism in hyperuricemia mice
  21. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  22. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  23. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  24. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  25. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  26. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  27. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  28. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  29. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  30. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  31. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  32. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  33. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  34. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  35. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  36. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  37. Low-pressure exposure influences the development of HAPE
  38. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  39. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  40. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  41. A case of bloodstream infection caused by Neisseria gonorrhoeae
  42. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  43. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  44. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  45. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  46. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  47. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  48. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  49. Sodium butyrate aids brain injury repair in neonatal rats
  50. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  51. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  52. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  53. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  54. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  55. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  56. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  57. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  58. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  59. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  60. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  61. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  62. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  63. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  64. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  65. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  66. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  67. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  68. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  69. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  70. Oncolytic bacteria: A revolutionary approach to cancer therapy
  71. A de novo meningioma with rapid growth: A possible malignancy imposter?
  72. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  73. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  74. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  75. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  76. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  77. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  78. Evaluation and application analysis of animal models of PIPNP based on data mining
  79. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  80. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  81. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  82. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  83. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  84. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  85. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  86. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  87. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  88. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  89. RNF144A and RNF144B: Important molecules for health
  90. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  91. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  92. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  93. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  94. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  95. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  96. Understanding risk factors and prognosis in diabetic foot ulcers
  97. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  98. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  99. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  100. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  101. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  102. Pulmonary cryptococcosis with headache as the first presentation: A case report
  103. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  104. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  105. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  106. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  107. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  108. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  109. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  110. Wound healing and signaling pathways
  111. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  112. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  113. Research progress on the impact of curcumin on immune responses in breast cancer
  114. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  115. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  116. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  117. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  118. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  119. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  120. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  121. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  122. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  123. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  124. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  125. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  126. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  127. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  128. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  129. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  130. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  131. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  132. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  133. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  134. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  135. Advances in cancer immunotherapy and future directions in personalized medicine
  136. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  137. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  138. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  139. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  140. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  141. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  142. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  143. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  144. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  145. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  146. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  147. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  148. Ecology and Environmental Science
  149. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  150. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  151. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  152. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  153. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  154. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  155. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  156. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  157. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  158. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  159. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  160. Agriculture
  161. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  162. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  163. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  164. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  165. Animal Science
  166. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  167. Plant Sciences
  168. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  169. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  170. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  171. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  172. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  173. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  174. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  175. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  176. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  177. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  178. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  179. Food Science
  180. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  181. Review on role of honey in disease prevention and treatment through modulation of biological activities
  182. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  183. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  184. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  185. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  186. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  187. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  188. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  189. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  190. The dilemma of food genetics and improvement
  191. Bioengineering and Biotechnology
  192. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  193. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  194. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  195. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  196. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  197. Corrigendum
  198. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  199. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  200. Retraction
  201. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 12.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0961/html
Scroll to top button